Literature DB >> 27081175

Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.

Pilar de la Puente1, Nancy Quan2, Ryan Soo Hoo2, Barbara Muz1, Rebecca C Gilson3, Micah Luderer1, Justin King4, Samuel Achilefu5, Noha Nabil Salama6, Ravi Vij4, Abdel Kareem Azab7.   

Abstract

Entities:  

Keywords:  malignant microenvironment; multiple myeloma; new cell line; stroma

Mesh：

Year:  2016        PMID： 27081175      PMCID： PMC5004479          DOI： 10.3324/haematol.2016.142190

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  23 in total

1.  Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.

Authors:  Y Nefedova; T H Landowski; W S Dalton
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

Review 2.  The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.

Authors:  Mark B Meads; Lori A Hazlehurst; William S Dalton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

Authors:  Teru Hideshima; Dharminder Chauhan; Toshiaki Hayashi; Klaus Podar; Masaharu Akiyama; Deepak Gupta; Paul Richardson; Nikhil Munshi; Kenneth C Anderson
Journal:  Mol Cancer Ther       Date:  2002-05       Impact factor: 6.261

4.  Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.

Authors:  Annemiek Broyl; Dirk Hose; Henk Lokhorst; Yvonne de Knegt; Justine Peeters; Anna Jauch; Uta Bertsch; Arjan Buijs; Marian Stevens-Kroef; H Berna Beverloo; Edo Vellenga; Sonja Zweegman; Marie-Josée Kersten; Bronno van der Holt; Laila el Jarari; George Mulligan; Hartmut Goldschmidt; Mark van Duin; Pieter Sonneveld
Journal:  Blood       Date:  2010-06-23       Impact factor: 22.113

5.  Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.

Authors:  Abdel Kareem Azab; Jinsong Hu; Phong Quang; Feda Azab; Costas Pitsillides; Rana Awwad; Brian Thompson; Patricia Maiso; Jessica D Sun; Charles P Hart; Aldo M Roccaro; Antonio Sacco; Hai T Ngo; Charles P Lin; Andrew L Kung; Ruben D Carrasco; Karin Vanderkerken; Irene M Ghobrial
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

Review 6.  The stem cell niche in health and malignancy.

Authors:  Monika L Burness; Dorothy A Sipkins
Journal:  Semin Cancer Biol       Date:  2010-05-25       Impact factor: 15.707

7.  Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.

Authors:  Yair Gazitt; Cagla Akay
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

8.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

9.  A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.

Authors:  Julia Kirshner; Kyle J Thulien; Lorri D Martin; Carina Debes Marun; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

10.  Markers for characterization of bone marrow multipotential stromal cells.

Authors:  Sally A Boxall; Elena Jones
Journal:  Stem Cells Int       Date:  2012-05-14       Impact factor: 5.443
View more
  5 in total

1.  Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.

Authors:  Pilar de la Puente; Micah J Luderer; Cinzia Federico; Abbey Jin; Rebecca C Gilson; Christopher Egbulefu; Kinan Alhallak; Shruti Shah; Barbara Muz; Jennifer Sun; Justin King; Daniel Kohnen; Noha Nabil Salama; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  J Control Release       Date:  2017-11-28       Impact factor: 9.776

2.  Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.

Authors:  Jennifer Sun; Barbara Muz; Kinan Alhallak; Matea Markovic; Shannon Gurley; Zhe Wang; Nicole Guenthner; Katherine Wasden; Mark Fiala; Justin King; Daniel Kohnen; Noha Nabil Salama; Ravi Vij; Abdel Kareem Azab
Journal:  Cancers (Basel)       Date:  2020-01-28       Impact factor: 6.639

3.  Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations.

Authors:  Kristin Calar; Simona Plesselova; Somshuvra Bhattacharya; Megan Jorgensen; Pilar de la Puente
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

4.  Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma.

Authors:  Sebastian A Dziadowicz; Lei Wang; Halima Akhter; Drake Aesoph; Tulika Sharma; Donald A Adjeroh; Lori A Hazlehurst; Gangqing Hu
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

5.  Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma.

Authors:  Johannes M Waldschmidt; Stefan J Fruttiger; Dagmar Wider; Johannes Jung; Andreas R Thomsen; Tanja N Hartmann; Justus Duyster; Martin J Hug; Kareem A Azab; Manfred Jung; Ralph Wäsch; Monika Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-24       Impact factor: 4.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.